CR-4892 series (Rottapharm)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCR-4892 series (Rottapharm)
Drug Alias NameNav 1.8 blockers (Rottapharm Madaus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRottapharm Madaus Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRottapharm Madaus Gmbh
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A